Name | 4,6,9a,11a-tetramethyl-1-(6-methylheptan-2-yl)-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinolin-7-one |
---|
Description | MK 386 (L-733692) is a selective 5-α-reductase I inhibitor, used for prostate cancer inhibition[1]. |
---|---|
Related Catalog | |
Target |
5-α-reductase I[1] |
References |
Density | 0.951g/cm3 |
---|---|
Boiling Point | 505.2ºC at 760mmHg |
Molecular Formula | C28H49NO |
Molecular Weight | 415.69 |
Flash Point | 203.9ºC |
Exact Mass | 415.38100 |
PSA | 20.31000 |
LogP | 7.11230 |
Vapour Pressure | 2.48E-10mmHg at 25°C |
Index of Refraction | 1.494 |